Secured Thyroidectomy With Intraoperative Methylene Blue Using

Thyroid Clinical Trial

— bluethyroid  

Official title:

Prospective Randomized Technical Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01347606
• Other study ID #: 4-Aysan
• Status: Recruiting
• Phase: N/A
• First received: May 3, 2011
• Last updated: May 3, 2011
• Start date: January 2010
• Est. completion date: July 2011

Study information

• Verified date: January 2010
• Source: SB Istanbul Education and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Turkey: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Thyroid surgery has potential risks. Intraoperative organ (such as parathyroides) extraction and vascular or neural (such as recurrent nervus) injuries are most important ones. This research is aim to prevention of these via intraoperative methylene blue using.

Description:

Thyroid surgery has potential risks. Intraoperative organ (such as parathyroides) extraction and vascular or neural (such as recurrent nervus) injuries are most important ones. This research is aim to prevention of these via intraoperative methylene blue using. In the operation when thyroid lobes manipulated to medially, methylene blue will be sprayed to this area. Dying patternes of tissues (thyroid tissue, oparathyroid tissues, arteries, venules and neural structures) will ensure to identification the tissues.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: July 2011
• Est. primary completion date: January 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Thyroidectomy indicated patients

Exclusion Criteria:

• Recurrent disease

• Additional disease

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Thyroid

Locations

Country	Name	City	State
Turkey	Bezmialem Vakif University	Istanbul

Sponsors (2)

Lead Sponsor	Collaborator
SB Istanbul Education and Research Hospital	Bezmialem Vakif University

Country where clinical trial is conducted

Turkey,